CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
4 research outputs found
Bacteria-eradicating therapy for ocular adnexal MALT lymphoma:Questions for an open international prospective trial [3]
Author
Cavalli F.
Doglioni C.
+6 more
Dognini G. P.
Dolcetti R.
Du M. Q.
Ferreri Andres J.M.
Ponzoni M.
Radford J.
Publication venue
'Oxford University Press (OUP)'
Publication date
01/11/2006
Field of study
No full text
The University of Manchester - Institutional Repository
A Dose Escalation Study of RP6530, a Novel Dual PI3K Delta/Gamma Inhibitor, in Patients with Relapsed/Refractory Hematologic Malignancies
Author
Andres J.M. Ferreri
Armando Santoro
+12 more
Carmelo Carlo-Stella
Lydia Scarfo
Paolo Ghia
Prajak J Barde
Richard Delarue
Sara Gandolfi
Silvia Laura Locatelli
Srikant Viswanadha
Swaroop Vakkalanka
Thamila Saheb
Uday Kumar
Valeria Pittari
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref
Feasibility and efficacy of high doses of antimetabolites followed by high-dose sequential chemoimmunotherapy (R-HDS) and autologous stem cell transplant (ASCT) in patients (pts) with systemic B-cell lymphoma (BCL) and central nervous system (CNS) involvement: A multicenter phase II trial.
Author
Alessandro Fanni
Alfonso D'Arco
+14 more
Andres J.M. Ferreri
Antonio Mulè
Caterina Patti
Corrado Tarella
Fabio Ciceri
Federico Caligaris-Cappio
Gianluca Doa
Giovanni Donadoni
Marco Foppoli
Maria Giuseppina Cabras
Marta Bruno Ventre
Massimo A. Di Nicola
Michael Mian
Renato Zambello
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
The Combination of Weekly Infusion of Rituximab and Bortezomib Is Effective in Relapsed or Refractory Indolent and Mantle Cell Lymphoma: Long-Term Results of Phase II BRIL06 Study of the Fondazione Italiana Linfomi (FIL)
Author
Alberto Fabbri
Alessandra Tucci
+19 more
Amalia De Renzo
Andrea Evangelista
Andres J.M. Ferreri
Anna Marina Liberati
Annalisa Chiappella
Chiara Rusconi
Delia Rota-Scalabrini
Domenico Novero
Francesco Zaja
Giorgina Specchia
Lorella Orsucci
Luigi Rigacci
Maurizio Martelli
Patrizia Pregno
Pier Luigi Zinzani
Roberto Freilone
Silvia Franceschetti
Umberto Vitolo
Vittorio Stefoni
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref